These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 14991961)

  • 1. The challenges of an HIV vaccine enterprise.
    Wolf H
    Science; 2004 Feb; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14991961
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine. The need for a global HIV vaccine enterprise.
    Klausner RD; Fauci AS; Corey L; Nabel GJ; Gayle H; Berkley S; Haynes BF; Baltimore D; Collins C; Douglas RG; Esparza J; Francis DP; Ganguly NK; Gerberding JL; Johnston MI; Kazatchkine MD; McMichael AJ; Makgoba MW; Pantaleo G; Piot P; Shao Y; Tramont E; Varmus H; Wasserheit JN
    Science; 2003 Jun; 300(5628):2036-9. PubMed ID: 12829768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-8 endorses new global HIV vaccine enterprise.
    Bull World Health Organ; 2004 Jul; 82(7):557. PubMed ID: 15500292
    [No Abstract]   [Full Text] [Related]  

  • 4. An HIV/AIDS vaccine: where do we go from here?
    Bernstein A
    Trends Microbiol; 2008 Dec; 16(12):553-4. PubMed ID: 18964019
    [No Abstract]   [Full Text] [Related]  

  • 5. New institute to focus on AIDS vaccine.
    AIDS Read; 2008 Nov; 18(11):551. PubMed ID: 19058408
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparations for AIDS vaccine evaluations. AIDS International Training and Research Program.
    Bridbord K
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S227-9. PubMed ID: 7865307
    [No Abstract]   [Full Text] [Related]  

  • 7. A joint clinical research center in Thailand: role in HIV vaccine development.
    Morgan PA; Chinaworapong S; Excler JL; Wongkamheng S; Triampon A; Buapunth P; Nitayaphan S; Michael RA; Singharaj P; Brown AE
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):126-35. PubMed ID: 12971525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [AIDS research update].
    Katlama C
    Soins; 2004; (687):40. PubMed ID: 15384774
    [No Abstract]   [Full Text] [Related]  

  • 9. An AIDS vaccine for all the world. Interview by Matthew O'Rourke.
    Berkley S
    AIDS Clin Care; 1999 Jul; 11(7):55-7, 62. PubMed ID: 11366434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The International AIDS Vaccine Initiative.
    Berkley S
    J Int Assoc Physicians AIDS Care; 1997 Nov; 3(11):30-4. PubMed ID: 11364811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan).
    Pitisuttithum P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashiro H; Manrique A; Bernstein A; Goyal R; Ditangco RA; Cooper DA; Osmanov S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Shao Y;
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1130-46. PubMed ID: 22299439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenges of an HIV vaccine enterprise.
    Zinkernagel RM
    Science; 2004 Feb; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14988536
    [No Abstract]   [Full Text] [Related]  

  • 13. NIAID will fund HIV vaccine trials network.
    Sweeney R; Lapp T
    Am Fam Physician; 2000 Aug; 62(4):717. PubMed ID: 10969851
    [No Abstract]   [Full Text] [Related]  

  • 14. Volunteers sought for NIH AIDS vaccine study.
    AIDS Read; 2005 Nov; 15(11):574. PubMed ID: 16329177
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS vaccines. The first shot in a highly targeted strategy.
    Cohen J
    Science; 2004 Nov; 306(5700):1276-7. PubMed ID: 15550634
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparations for AIDS vaccine trials. Respecting concerns of international host countries.
    Katongole-Mbidde E
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S187-9. PubMed ID: 7865297
    [No Abstract]   [Full Text] [Related]  

  • 17. Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
    Yearby R
    De Paul Law Rev; 2004; 53(3):1127-54. PubMed ID: 16200692
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparations for HIV vaccine trials: moving from baseline studies to efficacy trials.
    Hoff R
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S191-3. PubMed ID: 7865298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rocky road to an AIDS vaccine.
    Osborn JE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):26-9. PubMed ID: 7712231
    [No Abstract]   [Full Text] [Related]  

  • 20. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
    WHO/UNAIDS/IAVI International Expert Group
    AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.